Science and medicine are incredibly amazing. Thanks to modern science and medicine, we now have lifespans far beyond our Dark ...

CRISPR-Cas systems are adaptive immune systems found in prokaryotes that defend against invading nucleic acids through CRISPR ...

Even gene drives aimed at controlling malaria-carrying mosquitoes rely on CRISPR’s precision. Among CRISPR’s many variants, the compact Type V Cas12 enzymes—key players in genome editing, diagnostics, ...

Stanford researchers and their collaborators have revealed a new device that could change the way scientists conduct ...

Deep-pocketed investors have adopted a bearish approach towards CRISPR Therapeutics (NASDAQ:CRSP), and it's something market players shouldn't ignore. Our tracking of public options records at ...

Scientists developed a new nanostructure that triples CRISPR’s ability to enter cells, unlocking even more power to treat ...

CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at ...

That’s why a team from UC San Diego in La Jolla set out with Yale University researchers to develop a new system for gene ...

CRISPR Therapeutics AG is a long-term buy despite slow Casgevy uptake. Click for my updated look at CRSP earnings and the ...